CGMS

Electronic adhesives by Meridian EPO-TEK® highlighted at MD&M West

Retrieved on: 
Monday, February 5, 2024
Ultrasound, Electronics, CGMS, UV, MD, PZT, MED, ISO, Temperature, Commercial, Catheter, Anaheim Convention Center, Endoscopy, PCB, Medical device

CHARLOTTE, N.C., Feb. 5, 2024 /PRNewswire-PRWeb/ -- Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center.

Key Points: 
  • Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center
    CHARLOTTE, N.C., Feb. 5, 2024 /PRNewswire-PRWeb/ -- Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center.
  • The company's biocompatible/medical device grade adhesives are available in room temperature two-part systems or pre-mixed frozen single-component syringes.
  • Meridian will also highlight the EPO-TEK® "MED" line, which includes EPO-TEK® Biocompatible Medical Device Grade Products.
  • As a global manufacturer and custom formulator specializing in epoxy and UV adhesives, its focus is on medical device applications.

Two Guidehouse Professionals Earn Distinguished Grants Management Credential

Retrieved on: 
Tuesday, May 16, 2023
National Grants Management Association, State, Monitoring, NGMA, Financial services, Health, Accounting, Judgement, Rivers State Local Government Service Commission, Public sector, Sustainability, CGMS, Veritas Capital, Knowledge, Nursing

WASHINGTON, May 16, 2023 /PRNewswire/ -- Guidehouse, a leading global provider of consulting and managed services to public sector and commercial clients, is proud to announce that Katie Kirstein, associate director in the Health segment, and Lydia Vollmann, director in the State & Local Government practice, have earned the title of Certified Grants Management Specialist (CGMS) from the National Grants Management Association (NGMA). 

Key Points: 
  • The CGMS credential is a formal recognition of expert level knowledge of the full lifecycle of grants management.
  • Earning the credential demonstrates an individual's dedication to the highest standards of competency as a grants management professional and represents a strong commitment to ongoing professional development.
  • To obtain the CGMS credential, individuals must meet all eligibility requirements and demonstrate proficiency in grants management by passing the CGMS examination.
  • NGMA supports over 4,000 professionals across grants management, including supervisory, support, accounting, and compliance roles.

Eating Almonds Before Meals Improved Blood Sugar Levels in Some People with Prediabetes

Retrieved on: 
Wednesday, March 22, 2023
Breakfast, Exercise, Hyperglycemia, Insulin, Food, Diet, Zinc, Shoulder, Diabetes, Prevalence, Public, Magnesium, Glucose, Glucagon, DV, OGTT, Lipid, Vitamin E, C-reactive protein, Nutrient, Meal, Head, Research, Medicine, Almond, Prediabetes, Hormone, Human, A1C, Inborn errors of metabolism, Waist, Blood, National Diabetes Education Program, Professor, CGMS, Risk, C-peptide, Lunch, Overweight, Clutch (eggs), PPHG, Body mass index, Hunger, Potassium, Birth control, Dietary supplement, Pharmaceutical industry, Medical device, Obesity, Proinsulin, Endocrinology

MODESTO, Calif., March 22, 2023 /PRNewswire/ -- Two new research studies1-2 with almonds, one conducted over three days and the other over three months, demonstrated benefits to blood sugar control for Asian Indians with prediabetes and overweight/obesity – and the three-month almond intervention broke new ground, reversing prediabetes, or glucose intolerance, to normal blood sugar levels in nearly one quarter (23.3%) of the people studied.

Key Points: 
  • The findings complement the breadth of research on different populations on how almonds support healthy blood sugar as part of a balanced diet.
  • "Results from our studies indicate almonds might be a key differentiator in helping regulate blood glucose levels as part of a dietary strategy.
  • Eating 20 g of almonds 30 minutes before an oral glucose load showed a significant decrease in blood sugar and hormones.
  • These substantial metabolic improvements led to nearly one-fourth (23.3%) of the prediabetes study participants returning to normal blood glucose regulation.

SD Biosensor Successfully Finishes JP Morgan Healthcare Conference

Retrieved on: 
Friday, January 13, 2023
Insulin, GI, Glucose, FDA, CGMS, Conference, Diagnosis, PCR, SD, DX, Research, Biosensor, Antibody, Enzyme, Lead poisoning, Antigen, Multimedia, Pharmaceutical industry, Medical device, Meridian

SEOUL, South Korea, Jan. 13, 2023 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, successfully wrapped up its debut at the JP Morgan Healthcare Conference, the largest event in the pharmaceutical and bio-industry, on January 10 (local time), where they presented their corporate vision and holding one-on-one meetings.

Key Points: 
  • SEOUL, South Korea, Jan. 13, 2023 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, successfully wrapped up its debut at the JP Morgan Healthcare Conference, the largest event in the pharmaceutical and bio-industry, on January 10 (local time), where they presented their corporate vision and holding one-on-one meetings.
  • Meridian Bioscience Inc. ("Meridian"), which SD Biosensor decided to acquire last year, is mainly engaged in LS (Life Science) and DX (Diagnostics) businesses.
  • Meanwhile, SD Biosensor successfully completed its debut at the JP Morgan Healthcare Conference, holding one-on-one meetings with many investors on business development and investment during the conference.
  • SD Biosensor achieved the first place in the Korean pharmaceutical and bio-industry in terms of sales and operating profits in 2020 and 2021.

The Worldwide Next Generation Diabetes Therapy and Drug Delivery Industry is Expected to Reach $28 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Diabetes, Pharmaceutical, Health, Medical Devices, Adult, Diabetes, Porter's five forces analysis, Child, CGMS, Risk, Population, Growth, Needle, Patient, Insulin, Quality of life, Benchmarking, CGM, Skin, Awareness, Intensive care unit, Pharmaceutical industry

The global next generation diabetes therapy and drug delivery market is segmented based on product, demographic, indication, end user, and region.

Key Points: 
  • The global next generation diabetes therapy and drug delivery market is segmented based on product, demographic, indication, end user, and region.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the next generation diabetes therapy and drug delivery market analysis from 2020 to 2030 to identify the prevailing next generation diabetes therapy and drug delivery market opportunities.
  • In-depth analysis of the next generation diabetes therapy and drug delivery market segmentation assists to determine the prevailing market opportunities.
  • The report includes the analysis of the regional as well as global next generation diabetes therapy and drug delivery market trends, key players, market segments, application areas, and market growth strategies.

Digital Diabetes Management Market worth $25.5 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, April 22, 2022
Awareness, Government, Laboratory, Adoption, Lists of countries and territories, Obesity, LLC, Population, Tablet, LifeScan, Incidence, Hospital, Patient, Urbanization, Growth, Abbott Laboratories, Beato, CGM, Solution, Glooko, USD, Diabetes, CGMS, Prevalence, Tandem Diabetes Care, Medical device, Pharmaceutical industry, Medtronic, Lancet

On the basis of products and services, the diabetes management market is categorized into four major segments, namely, devices, apps, data management software & platforms, and services.

Key Points: 
  • On the basis of products and services, the diabetes management market is categorized into four major segments, namely, devices, apps, data management software & platforms, and services.
  • Based on type, the digital diabetes management devices market is segmented into handheld devices and wearable devices.
  • Wearable devices accounted for the largest share of 60.3% of the digital diabetes management devices market in 2021.
  • Based on end user, the diabetes management market is segmented into self/home healthcare, hospitals & specialty diabetes clinics, and academic & research institutes.

Digital Diabetes Management Market worth $25.5 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, April 22, 2022
Awareness, Government, Laboratory, Adoption, Lists of countries and territories, Obesity, LLC, Population, Tablet, LifeScan, Incidence, Hospital, Patient, Urbanization, Growth, Abbott Laboratories, Beato, CGM, Solution, Glooko, USD, Diabetes, CGMS, Prevalence, Tandem Diabetes Care, Medical device, Pharmaceutical industry, Medtronic, Lancet

On the basis of products and services, the diabetes management market is categorized into four major segments, namely, devices, apps, data management software & platforms, and services.

Key Points: 
  • On the basis of products and services, the diabetes management market is categorized into four major segments, namely, devices, apps, data management software & platforms, and services.
  • Based on type, the digital diabetes management devices market is segmented into handheld devices and wearable devices.
  • Wearable devices accounted for the largest share of 60.3% of the digital diabetes management devices market in 2021.
  • Based on end user, the diabetes management market is segmented into self/home healthcare, hospitals & specialty diabetes clinics, and academic & research institutes.

Advanced Human Imaging Announces Shift in Leadership

Retrieved on: 
Tuesday, February 15, 2022
ASX, Health, NASDAQ, Private Securities Litigation Reform Act, Ministry of Education (Malaysia), Collection, Tax, Form, CEO, Head, Risk, Company, Entrepreneurship, Forward-looking statement, U.S. Securities and Exchange Commission, Solution, AHI, Security (finance), Goal, Board of directors, Machine learning, Technology, Method, Computer vision, MHealth, Type 1 diabetes, Director, Publication, ATO, Board, Employment, Infratil, Growth, Nature, Biomedical Research, SEC filing, Life, Industry, CGMS, Smartphone, Management, Risk management, Online shopping

PERTH, Australia, Feb. 15, 2022 /PRNewswire/ --Advanced Human Imaging Limited (ASX:"AHI") (NASDAQ:"AHI")announced today that Nick Prosser has been appointed interim Non-executive Chairman of Advanced Human Imaging.

Key Points: 
  • PERTH, Australia, Feb. 15, 2022 /PRNewswire/ --Advanced Human Imaging Limited (ASX:"AHI") (NASDAQ:"AHI")announced today that Nick Prosser has been appointed interim Non-executive Chairman of Advanced Human Imaging.
  • We look forward to growing and capturing a larger global market share due to the innovation, solutions and robust leadership of Advanced Human Imaging."
  • "As a co-founder of Advanced Human Imaging, I'm pleased with the company's growth since its inception in 2014," said Dr. Iscoe.
  • I want to assure all shareholders that I will remain focused on Advanced Human Imaging, the company I love and co-founded.

Tomorrow.io Briefs WMO Community on Plans for Weather Satellite Constellation

Retrieved on: 
Monday, January 10, 2022
Ford Motor Company, Uber, Person, U.S. Securities and Exchange Commission, Weather, CIO, Water cycle, Radar, CGMS, OCP, COO, Organization, World Meteorological Organization, Delta, Acquisition, Proxy, Security (finance), Flood, Sale, Science, Meteorology, CEO, TMW, Private Securities Litigation Reform Act, WMO, National Wildfire Coordinating Group, SEC, AmTrust Bank, Form, SPAC, Founder, Water, Public sector, Atmosphere of Earth, United, Survival, Climate, Novum, National Grid, THE, Risk, Industry, Forward-looking statement, World, Tomorrow.io, Renewable energy, Communications satellite, Public relations, Nasdaq

BOSTON, Jan. 10, 2022 /PRNewswire/ -- The Tomorrow Companies Inc. ("Tomorrow.io"), developer of a leading platform for global weather and climate security, the World Meteorological Organization (WMO), and the Coordination Group for Meteorological Satellites (CGMS) came together virtually on Dec. 14 for a robust discussion on the emerging needs, recent advancement, and potential impacts of the space-based observing system for precipitation.

Key Points: 
  • On average, 60 percent of WMO member meteorological agencies lack the full capacity needed to provide observations or climate services for water.
  • This limits the ability to generate reliable weather forecasts and provide critical information about hurricanes, typhoons, floods and other extreme weather events.
  • "It was an honor to present our satellite constellation plans to the WMO and its member agencies," said Rei Goffer, Co-founder and Chief Strategy Officer for Tomorrow.io.
  • Tomorrow.io is The World's Weather and Climate Security Platform, helping countries, businesses, and individuals manage their weather and climate security challenges.